Role of multidrug resistance associated proteins in drug development.

Zhou SF

Drug Discov Ther. 2008; 2(6):305-332.

Summary Full Text (PDF)

Pharmacogenomics-based clinical studies using a novel, fully automated genotyping system.

Hasegawa S, Kimura S, Kobayashi A, Imanishi N

Drug Discov Ther. 2008; 2(6):333-338.

Summary Full Text (PDF)

Apoptosis-inducing effect of cinobufacini, Bufo bufo gargarizans Cantor skin extract, on human hepatoma cell line BEL-7402.

Qi FH, Li AY, Lv H, Zhao L, Li JJ, Gao B, Tang W

Drug Discov Ther. 2008; 2(6):339-343.

Summary Full Text (PDF)

Part 2. Long term in vivo/in vitro evaluation of the Cholecystokinin antagonists: N-(5-methyl-3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylurea MPP and carboxamide MPM.

Lattmann E, Boonprakob Y, Sattayasai J

Drug Discov Ther. 2008; 2(6):344-352.

Summary Full Text (PDF)

Pioglitazone attenuates tactile allodynia and microglial activation in mice with peripheral nerve injury.

Iwai S, Maeda T, Kiguchi N, Kobayashi Y, Fukazawa Y, Ozaki M, Kishioka S

Drug Discov Ther. 2008; 2(6):353-356.

Summary Full Text (PDF)

Phenolphthalein treatment in pregnant women and congenital abnormalities in their offspring: A population-based case-control study.

Bánhidy F, Ács N, Puhó EH, Czeizel AE

Drug Discov Ther. 2008; 2(6):357-367.

Summary Full Text (PDF)

Author Index (PDF)

Drug Discov Ther. 2008; 2(6):358-371.

Summary Full Text (PDF)

Subject Index (PDF)

Drug Discov Ther. 2008; 2(6):372-378.

Summary Full Text (PDF)